TITLE

Inducing apoptosis of human colon cancer cells by an IGF-I D domain analogue peptide

AUTHOR(S)
Shi Yu Yang; Sales, Kevin M.; Fuller, Barry J.; Seifalian, Alexander M.; Winslet, Marc C.
PUB. DATE
January 2008
SOURCE
Molecular Cancer;2008, Vol. 7, Special section p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: The resistance of tumour cells to apoptosis is a major contributor to the limited effectiveness of chemotherapies. Insulin-like growth factor I (IGF-I) has potential to protect cancer cells from variety of apoptotic challenges. This study was carried out to investigate the effect of a novel IGF-I receptor antagonist on apoptosis in colon cancer cells. Results: We have designed and synthesised a novel antagonist of IGF-I receptor. The effect of this antagonist on human colon cancer cell proliferation was examined by a non-radioactive assay; the apoptosis was revealed by determining the activities of cellular caspases3/7, 8 and 9. The apoptosis pathways were investigated by examining the levels of pro-apoptosis proteins with Western blotting. Following 40 hours treatment with the novel antagonist peptide, colon cancer cell Caspase 3/7 activities increased 2-7 times; Caspase 8 activities increased 2-5 times and Caspase 9 increased 1.2-1.6 times. The proliferation of cancer cell was inhibited by 14-15%. The data showed that the antagonist induced colon cancer cell apoptosis and inhibited cancer cell proliferation. The different changes of Caspase 3/7, 8 and 9 activities suggested that the extrinsic pathways may play a major role in the antagonist peptide-induced apoptosis. Conclusion: This is the first report on this novel antagonist to induce human colon cancer cell apoptosis and inhibit cancer cell proliferation. These results suggest that IGF-I receptor antagonists may have the potential to be developed as a novel therapy for colon cancers in the future.
ACCESSION #
35703537

 

Related Articles

  • Inducing apoptosis of human colon cancer cells by an IGF-I D domain analogue peptide. Shi Yu Yang; Sales, Kevin M.; Fuller, Barry J.; Seifalian, Alexander M.; Winslet, Marc C. // Molecular Cancer;2008, Vol. 7, Special section p1 

    Background: The resistance of tumour cells to apoptosis is a major contributor to the limited effectiveness of chemotherapies. Insulin-like growth factor I (IGF-I) has potential to protect cancer cells from variety of apoptotic challenges. This study was carried out to investigate the effect of...

  • Sorafenib Triggers Antiproliferative and Pro-Apoptotic Signals in Human Esophageal Adenocarcinoma Cells. Jorge-Shmuel Delgado; Reba Mustafi; Jason Yee; Sonia Cerda; Anusara Chumsangsri; Urszula Dougherty; Lev Lichtenstein; Alessandro Fichera; Marc Bissonnette // Digestive Diseases & Sciences;Dec2008, Vol. 53 Issue 12, p3055 

    Abstract   Background and purpose Current therapies offer scant benefit to patients with advanced esophageal adenocarcinoma. We investigated the effects of Sorafenib, a multifunctional kinase inhibitor, on several growth regulatory pathways that control cell growth and survival in SEG-1...

  • The anticancer effect of oridonin is mediated by fatty acid synthase suppression in human colorectal cancer cells. Kwan, Hiu-Yee; Yang, Zhijun; Fong, Wang-Fun; Hu, Yong-Mei; Yu, Zhi-Ling; Hsiao, Wen-Luan // Journal of Gastroenterology;Feb2013, Vol. 48 Issue 2, p182 

    Background: Fatty acid synthase (FAS) inhibitors could be a therapeutic target in cancer treatment. However, only a few FAS inhibitors showing clinical potential have been reported. Oridonin is a diterpenoid isolated from Rabdosia rubescens. Although it has antiproliferative activity in cancers,...

  • CysLT1R Antagonists Inhibit Tumor Growth in a Xenograft Model of Colon Cancer. Savari, Sayeh; Liu, Minghui; Zhang, Yuan; Sime, Wondossen; Sjölander, Anita // PLoS ONE;Sep2013, Vol. 8 Issue 9, p1 

    The expression of the inflammatory G-protein coupled receptor CysLT1R has been shown to be upregulated in colon cancer patients and associated with poor prognosis. The present study investigated the correlation between CysLT1R and colon cancer development in vivo using CysLT1R antagonists...

  • Inhibition of Hyaluronan Synthase-3 Decreases Subcutaneous Colon Cancer Growth by Increasing Apoptosis. Teng, Brian P.; Heffler, Melissa D.; Lai, Eric C.; Zhao, Ya-Li; LeVea, Charles M.; Golubovskaya, Vita M.; BullardDunn, Kelli M. // Anti-Cancer Agents in Medicinal Chemistry;2011, Vol. 11 Issue 7, p620 

    Hyaluronan (HA) and hyaluronan synthases (HAS) have been implicated in cancer growth and progression. We previously have shown that HAS3 and HA mediate tumor growth in SW620 colon cancer cells, but the mechanism remains poorly understood. In addition, the effect of HAS3 inhibition on tumor...

  • Preclinical studies of Apogossypolone: a new nonpeptidic pan small-molecule inhibitor of Bcl-2, Bcl-XL and Mcl-1 proteins in Follicular Small Cleaved Cell Lymphoma model. Arnold, Alan A.; Aboukameel, Amro; Jianyong Chen; Dajun Yang; Shaomeng Wang; Al-Katib, Ayad; Mohammad, Ramzi M. // Molecular Cancer;2008, Vol. 7, Special section p1 

    Elevated expression of anti-apoptotic Bcl-2 family proteins have been linked to a poor survival rate of patients with Follicular Lymphoma (FL). This prompted us to evaluate a very potent non-peptidic Small-Molecule Inhibitor (SMI) targeting Bcl-2 family proteins, Apogossypolone (ApoG2) using...

  • Readthrough of Premature Termination Codons in the Adenomatous Polyposis Coli Gene Restores Its Biological Activity in Human Cancer Cells. Floquet, Célia; Rousset, Jean-Pierre; Bidou, Laure // PLoS ONE;2011, Vol. 6 Issue 8, p1 

    The APC tumor suppressor gene is frequently mutated in human colorectal cancer, with nonsense mutations accounting for 30% of all mutations in this gene. Reintroduction of the WT APC gene into cancer cells generally reduces tumorigenicity or induces apoptosis. In this study, we explored the...

  • Epigallocatechin-3-gallate inhibits proliferation and migration of human colon cancer SW620 cells in vitro. Zhou, Fang; Zhou, Hong; Wang, Ting; Mu, Yuan; Wu, Biao; Guo, Dong-lin; Zhang, Xian-mei; Wu, Ying // Acta Pharmacologica Sinica;Jan2012, Vol. 33 Issue 1, p120 

    Aim:Epigallocatechin-3-gallate (EGCG) is the major polyphenolic constituent in green tea. The aim of this study is to investigate the effects of EGCG on proliferation and migration of the human colon cancer SW620 cells.Methods:Proliferation and migration of SW620 cells were induced by the...

  • microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis. Zhang, N; Li, X; Wu, C W; Dong, Y; Cai, M; Mok, M T S; Wang, H; Chen, J; Ng, S S M; Chen, M; Sung, J J Y; Yu, J // Oncogene;10/17/2013, Vol. 32 Issue 42, p5078 

    Using microRNA (miRNA) expression array, we identified that miR-7 was deregulated in colorectal cancer (CRC). We studied the biological role and molecular target of miR-7 in CRC. miR-7 was downregulated in six out of seven colon cancer cell lines. Ectopic expression of miR-7 suppressed colon...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics